Seer(SEER) - 2023 Q1 - Earnings Call Transcript

The oral presentation covers the first look at the Alzheimer's disease cohort of approximately 1,800 plasma samples using our next product which is in the hands of several early access customers. One customer study of note at ASMS is from Dr. Steve Carr's lab at the Broad Institute. Dr.Carr will have an oral presentation, demonstrating the performance of the Proteograph in plasma from multiple myeloma patients using the Bruker timsTOF HT and dia-PASEF. These results are particularly exciting as they show ho ...